psicheck2-B4GALT3
(Plasmid
#203601)
-
PurposeReporter plasmid carrying B4GALT3 3'UTR
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 203601 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepsicheck2
-
Backbone manufacturerPromega
- Backbone size w/o insert (bp) 6273
- Total vector size (bp) 6780
-
Modifications to backboneThe 3'UTR (nt 1800-2330) of B4GALT3 was inserted between XhoI and NotI in psicheck2.
-
Vector typeMammalian Expression, Luciferase
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namebeta-1,4-galactosyltransferase 3
-
SpeciesH. sapiens (human)
-
Insert Size (bp)451
-
Mutationnt 1800-2330 3'UTR
-
GenBank IDNM_001199873.1
-
Entrez GeneB4GALT3 (a.k.a. beta4Gal-T3)
- Promoter SV40
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XhoI (not destroyed)
- 3′ cloning site NotI (not destroyed)
- 5′ sequencing primer gtggagcgcgtgctgaagaac
- 3′ sequencing primer ccgcgaggtccgaagactc (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
psicheck2-B4GALT3 was a gift from Hiroyuki Mizuguchi (Addgene plasmid # 203601 ; http://n2t.net/addgene:203601 ; RRID:Addgene_203601) -
For your References section:
miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cells. Sakai E, Imaizumi T, Suzuki R, Taracena-Gandara M, Fujimoto T, Sakurai F, Mizuguchi H. Commun Biol. 2023 Jun 24;6(1):669. doi: 10.1038/s42003-023-05049-w. 10.1038/s42003-023-05049-w PubMed 37355744